Ken Tindall has been responsible for the Biotechnology Center's Science and Business Development efforts since 2000.
Ken oversees the Biotechnology Center's Business and Technology Development, Science and Technology Development, Education and Training, and Centers of Innovation programs. These four programs currently administer 17 grant and loan programs and since 2000 have allocated more than $35 million in grants and loans to support North Carolina research programs, educational activities and biotechnology businesses.
Previously, he was a tenured geneticist in the intramural research program at the National Institute of Environmental Health Sciences (NIEHS). Ken's scientific expertise is in molecular mutagenesis and DNA repair, specifically on the mechanisms whereby mutations contribute to genomic instability, leading to genetic dysfunctions associated with cancer and human genetic disease.
At NIEHS, he was also responsible for the commercialization of a transgenic mouse used in drug safety studies. He earned a B.S and M.S. from Montana State University and a Ph.D. in genetics at the Biology Division of the Oak Ridge National Lab. Ken held post-doctoral fellow and faculty appointments at Yale University prior to joining NIEHS.
From 2000 - 2007, Ken served as the president of the Biotechnology Center-sponsored North Carolina Genomics and Bioinformatics Consortium. Since 1994, he has been an adjunct professor in the Curriculum in Toxicology at the University of North Carolina at Chapel Hill.